functional dyspepsia
Jump to navigation
Jump to search
Introduction
At least 3 months of pain or discomfort centered in the upper abdomen, without clinical, endoscopic, or ultrasonographic evidence of known organic disease likely to explain the symptoms.
Etiology
(differential diagnosis)
- gastroesophageal reflux disease (GERD)*
- irritable bowel syndrome (IBS)*
- peptic ulcer disease (PUD) is an uncommon cause
- gallstones
* 75% of cases are due to GERD &/or IBS
Pathology
- dysfunctional gastric acid secretion
- gastrointestinal dysmotility -> gastroparesis*
- psychosocial factors
* essentially the same disorder as gastroparesis[4]
Clinical manifestations
- ulcer-like dyspepsia
- epigastric pain
- relieved by food
- relieved by antacids or H2 receptor antagonists
- occurs before meals or when hungry
- awakens patients from sleep
- periodic: weeks to months with pain with intermittent remissions of weeks without pain
- dysmotility-like dyspepsia
- abdominal discomfort (pain is infrequent)
- early satiety
- postprandial fullness
- nausea
- recurrent wretching or vomiting
- bloating in the upper abdomen, not accompanied by visible distension
- upper abdominal discomfort often aggravated by food
- gastroparesis*
* essentially the same disorder as gastroparesis[4]
Diagnostic criteria
- bothersome postprandial symptoms
- early satiety
- epigastric pain &/or burning
- symptoms for past 3 months
- symptom onset at least 6 months previously
- no evidence of structural disease to explain symptoms[1]
Laboratory
- endoscopy
- 24 hours esophageal pH monitoring
- serology for Helicobacter pylori
Management
- diet & lifestyle modification[1]
- benefit proton pump inhibitor short-lived
- benefit at 4 weeks, but not at 8 weeks[2]
- low-dose tricyclic antidepressant if poor response to once daily proton pump inhibitor[1]
- cognitive behavioral therapy
- probiotics Bacillus subtilis & Bacillus coagulans may be of benefit
More general terms
Additional terms
- cholelithiasis (gallstones)
- gastroesophageal reflux disease (GERD)
- gastroparesis
- Helicobacter pylori
- irritable bowel syndrome (IBS)
- peptic ulcer disease (PUD)
References
- ↑ 1.0 1.1 1.2 1.3 Medical Knowledge Self Assessment Program (MKSAP) 11, 17, 18. American College of Physicians, Philadelphia 1998, 2015, 2018
- ↑ 2.0 2.1 van Zanten SV et al, Esomeprazole 40 mg once a day in patients with functional dyspepsia: The radomized, placebo-controlled 'ENTER' trial. Am J Gastroenterol 2006, 101:2096 PMID: https://www.ncbi.nlm.nih.gov/pubmed/16817845
- ↑ Lacy BE, Talley NJ, Locke GR 3rd et al Review article: current treatment options and management of functional dyspepsia. Aliment Pharmacol Ther. 2012 Jul;36(1):3-15. Epub 2012 May 16. PMID: https://www.ncbi.nlm.nih.gov/pubmed/22591037
- ↑ 4.0 4.1 4.2 Pasricha PJ et al. Functional dyspepsia and gastroparesis in tertiary care are interchangeable syndromes with common clinical and pathologic features. Gastroenterology 2021 May; 160:2006. PMID: https://www.ncbi.nlm.nih.gov/pubmed/33548234 https://www.gastrojournal.org/article/S0016-5085(21)00337-1/fulltext
Tack J et al. Gastroparesis: A dead-end street after all? Gastroenterology 2021 May; 160:1931. PMID: https://www.ncbi.nlm.nih.gov/pubmed/33621562 https://www.gastrojournal.org/article/S0016-5085(21)00432-7/fulltext - ↑ Hamza Z Probiotics Show Promise for Symptoms of Functional GI Disorders. Small pilot study suggested clinical benefit, acceptable safety profile. https://www.medpagetoday.com/gastroenterology/generalgastroenterology/93951
Wauters L, Slaets H, De Paepe K et al Efficacy and safety of spore-forming probiotics in the treatment of functional dyspepsia: a pilot randomised, double-blind, placebo-controlled trial. Lancet Gastroenterol Hepatol 2021; Aug 3. PMID: https://www.ncbi.nlm.nih.gov/pubmed/34358486 https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00226-0/fulltext
Burns GL, Hoedt EC, Keely S Spore-forming probiotics for functional dyspepsia. Lancet Gastroenterol Hepatol 2021; Aug 3. PMID: https://www.ncbi.nlm.nih.gov/pubmed/34358485 https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00260-0/fulltext